Asset Details
Do you wish to reserve the book?
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
Do you wish to request the book?
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
2021
Overview
BackgroundCOVID-19 patients present with delirium during their hospitalization.AimsTo assess the incidence of delirium in hospitalized COVID-19 patients and analyze the possible association with demographic, clinical, laboratory, and pharmacological factors.MethodsCOVID-19 patients were assessed for clinical signs of delirium and administered the assessment test for delirium and cognitive impairment (4AT) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scales.ResultsOut of the 56 patients of our cohort, 14 (25.0%) experienced delirium. The use of low molecular weight heparin (LMWH) (enoxaparin 1 mg/kg/daily) was less frequent in patients with delirium (p = 0.004) and was accompanied by lower C reactive protein (CRP) levels (p = 0.006).DiscussionThe use of LMWH was associated with absence of delirium, independently of comorbidities and age.ConclusionsThe use of LMWH may help preventing the occurrence of delirium in COVID-19 patients, with possible reduction of length of stay in the hospital and sequelae.
Publisher
Springer Nature B.V
Subject
